
Introducing

India’s first clinically proven NIBS wearable designed to improve brain health and executive functioning.
NIBS = Non-Invasive Brain Stimulation
Treat
depressionwithout side
effects
with Mave Health's 12 week program.88% Mavericks improved their mental health with our 12 week program, get started with your personalised program now.
science behind the wearable
tDCS is a clinically proven
Non Invasive Brain Stimulation technology.
Non Invasive Brain Stimulation technology.

CE certified technology

Researched in AIIMS & NIMHANS
The tDCS Protocol
One 30-min session/day, for
21 days helps 65% Mavericks see significant improvement in their scores.
21 days helps 65% Mavericks see significant improvement in their scores.
Improvement88%
Remission72%
21
sessions
Each lasting
30
mins/session
For
21
days
21
sessions
Each lasting
30
mins/session
For
21
days
3L+
Sessions administered with zero side effects to more than 10,000 people.
Safe add-on to medicines
Compliments therapy
Ideal for recovery maintenance
User friendly experience
What makes Mave stand apart
India′s first at-home neuro-therapy
Highly effective for symptom relief
Trusted judgement-free experts
Treat depression
without side effects
with Mave Health's program
without side effects
with Mave Health's program
3 Lac+
tDCS Sessions administered globally.
10K+
Published
clinical trials on tDCS.
20+ yrs
Spent on tDCS research.
88% Mavericks improved their mental health with our 12 week program, get started with your personalised program now.
Mave Health v/s
traditional solutions
traditional solutions

CE certified technology
Individuals with improvement in depression score
Percentage of patients who report side effects
Individuals with improvement in depression score

CE certified technology
Percentage of patients who report side effects
Frequently
asked
questions
asked
questions
Join our 12 week program to get on the path back from depression.
88% Mavericks improved their mental health with our 12 week program, get started with your personalised program now.